Provided by Tiger Trade Technology Pte. Ltd.

Mettler-Toledo

1,401.00
+2.420.17%
Volume:70.69K
Turnover:98.56M
Market Cap:28.07B
PE:31.52
High:1,405.09
Open:1,385.74
Low:1,376.24
Close:1,398.58
52wk High:1,525.17
52wk Low:1,023.05
Shares:20.04M
Float Shares:19.97M
Volume Ratio:0.55
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):44.45
EPS(LYR):42.05
ROE:2951.46%
ROA:21.10%
PB:2189.13
PE(LYR):33.32

Loading ...

Mettler-Toledo Lifts EPS Outlook Amid Tariff Drag

TIPRANKS
·
Jun 02

Mettler-Toledo initiated with a Peer Perform at Wolfe Research

TIPRANKS
·
Jun 02

Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma

GlobeNewswire
·
May 31

Mettler-Toledo International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 30

Mettler-Toledo International Inc. Stock Rises 6.4%, Outperforms Peers

Dow Jones
·
May 29

Press Release: Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution -- Section 19(a) Notice

Dow Jones
·
May 28

Press Release: BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
May 27

Mettler-Toledo International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 23

Mettler-Toledo International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 21

Mettler-Toledo International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 19

IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing

GlobeNewswire
·
May 19

Mettler-Toledo price target lowered to $1,400 from $1,600 at Stifel

TIPRANKS
·
May 18

How Investors Are Reacting To Mettler-Toledo International (MTD) Q1 Beat And 2026 Sales Growth Outlook

Simply Wall St.
·
May 18

GT Biopharma Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 15

Mettler-Toledo International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 15

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program

GlobeNewswire
·
May 14

Mettler-Toledo International Inc. Stock Slides 4.4%, Underperforms Peers

Dow Jones
·
May 14

Mettler-Toledo Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
May 13

Mettler-Toledo price target lowered to $1,275 from $1,475 at Morgan Stanley

TIPRANKS
·
May 12

Morgan Stanley Cuts Price Target on Mettler-Toledo International to $1,275 From $1,475, Keeps Equalweight Rating

MT Newswires Live
·
May 12